• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫疗法能否增强化疗疗效?结直肠癌治疗的新视角。

Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment.

机构信息

Department of Gastroenterology, Jinhua Wenrong Hospital, Jinhua, Zhejiang, China.

Department of Surgical Oncology, Hangzhou Cancer Hospital, Hangzhou, Zhejiang, China.

出版信息

Front Immunol. 2023 Sep 18;14:1237764. doi: 10.3389/fimmu.2023.1237764. eCollection 2023.

DOI:10.3389/fimmu.2023.1237764
PMID:37790928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10543914/
Abstract

As one of the main threats to human life (the fourth most dangerous and prevalent cancer), colorectal cancer affects many people yearly, decreases patients' quality of life, and causes irreparable financial and social damages. In addition, this type of cancer can metastasize and involve the liver in advanced stages. However, current treatments can't completely eradicate this disease. Chemotherapy and subsequent surgery can be mentioned among the current main treatments for this disease. Chemotherapy has many side effects, and regarding the treatment of this type of tumor, chemotherapy can lead to liver damage, such as steatohepatitis, steatosis, and sinus damage. These damages can eventually lead to liver failure and loss of its functions. Therefore, it seems that other treatments can be used in addition to chemotherapy to increase its efficiency and reduce its side effects. Biological therapies and immunotherapy are one of the leading suggestions for combined treatment. Antibodies (immune checkpoint blockers) and cell therapy (DC and CAR-T cells) are among the immune system-based treatments used to treat tumors. Immunotherapy targets various aspects of the tumor that may lead to 1) the recruitment of immune cells, 2) increasing the immunogenicity of tumor cells, and 3) leading to the elimination of inhibitory mechanisms established by the tumor. Therefore, immunotherapy can be used as a complementary treatment along with chemotherapy. This review will discuss different chemotherapy and immunotherapy methods for colorectal cancer. Then we will talk about the studies that have dealt with combined treatment.

摘要

作为威胁人类生命的主要因素之一(第四大最危险和普遍的癌症),结直肠癌每年影响许多人,降低患者的生活质量,并造成不可挽回的经济和社会损失。此外,这种癌症可以转移并在晚期累及肝脏。然而,目前的治疗方法无法完全治愈这种疾病。化疗和随后的手术可以被提及作为这种疾病的主要治疗方法之一。化疗有许多副作用,而对于这种类型肿瘤的治疗,化疗会导致肝脏损伤,如脂肪性肝炎、脂肪变性和窦损伤。这些损伤最终可能导致肝功能衰竭和丧失功能。因此,似乎可以除化疗之外使用其他治疗方法来提高其效率并减少其副作用。生物疗法和免疫疗法是联合治疗的主要建议之一。抗体(免疫检查点抑制剂)和细胞疗法(DC 和 CAR-T 细胞)是用于治疗肿瘤的基于免疫系统的治疗方法之一。免疫疗法针对肿瘤的各个方面,这些方面可能导致 1)免疫细胞的募集,2)增加肿瘤细胞的免疫原性,和 3)导致肿瘤建立的抑制机制的消除。因此,免疫疗法可以与化疗一起作为辅助治疗。这篇综述将讨论结直肠癌的不同化疗和免疫疗法方法。然后,我们将讨论已经涉及联合治疗的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd66/10543914/d98b02715ba8/fimmu-14-1237764-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd66/10543914/af1949cbefcc/fimmu-14-1237764-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd66/10543914/d98b02715ba8/fimmu-14-1237764-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd66/10543914/af1949cbefcc/fimmu-14-1237764-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd66/10543914/d98b02715ba8/fimmu-14-1237764-g002.jpg

相似文献

1
Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment.免疫疗法能否增强化疗疗效?结直肠癌治疗的新视角。
Front Immunol. 2023 Sep 18;14:1237764. doi: 10.3389/fimmu.2023.1237764. eCollection 2023.
2
Colorectal Cancer Immunotherapy: Options and Strategies.结直肠癌免疫治疗:选择与策略。
Front Immunol. 2020 Sep 18;11:1624. doi: 10.3389/fimmu.2020.01624. eCollection 2020.
3
T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.T细胞免疫球蛋白和免疫酪氨酸抑制基序结构域,作为结直肠癌免疫治疗的潜在免疫检查点靶点。
IUBMB Life. 2021 May;73(5):726-738. doi: 10.1002/iub.2461. Epub 2021 Mar 30.
4
Perspectives on Treatment of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitor Therapy.免疫检查点抑制剂治疗转移性结直肠癌的观点。
Oncologist. 2020 Jan;25(1):33-45. doi: 10.1634/theoncologist.2019-0176. Epub 2019 Aug 5.
5
Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study.自体树突状细胞联合细胞因子诱导的杀伤细胞继以化疗治疗晚期结直肠癌患者的临床疗效:一项前瞻性研究
Tumour Biol. 2016 Apr;37(4):4367-72. doi: 10.1007/s13277-015-3957-2. Epub 2015 Oct 24.
6
[Looking back 2018--focused on colorectal cancer].回首2018——聚焦结直肠癌
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jan 25;22(1):9-16.
7
The potential role of immunotherapy to treat colorectal cancer.免疫疗法在治疗结直肠癌中的潜在作用。
Expert Opin Investig Drugs. 2015 Mar;24(3):329-44. doi: 10.1517/13543784.2015.985376. Epub 2014 Dec 17.
8
Colorectal cancer immunotherapy-Recent progress and future directions.结直肠癌免疫治疗——最新进展与未来方向。
Cancer Lett. 2022 Oct 1;545:215816. doi: 10.1016/j.canlet.2022.215816. Epub 2022 Jul 8.
9
Clinical significance of immunotherapy with combined three kinds of cells for operable colorectal cancer.三种细胞联合免疫治疗对可切除结直肠癌的临床意义
Tumour Biol. 2015 Jul;36(7):5679-85. doi: 10.1007/s13277-015-3242-4. Epub 2015 Mar 13.
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

引用本文的文献

1
Adoptive cell therapy in colorectal cancer: Advances in chimeric antigen receptor T cells.结直肠癌中的过继性细胞疗法:嵌合抗原受体T细胞的进展
World J Gastrointest Oncol. 2025 Jul 15;17(7):106723. doi: 10.4251/wjgo.v17.i7.106723.
2
CD55 may be a new target for colorectal cancer treatment.CD55可能是结直肠癌治疗的一个新靶点。
Sci Rep. 2025 Jul 2;15(1):23086. doi: 10.1038/s41598-025-08491-4.
3
Advancing targeted therapy for colorectal cancer: harnessing ligand-directed enzyme prodrug therapy for highly specific interventions.

本文引用的文献

1
Intratumor heterogeneity and cell secretome promote chemotherapy resistance and progression of colorectal cancer.肿瘤内异质性和细胞分泌组促进结直肠癌的化疗耐药和进展。
Cell Death Dis. 2023 May 5;14(5):306. doi: 10.1038/s41419-023-05806-z.
2
Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape.错配修复缺陷/微卫星高度不稳定型结直肠癌领域的挑战与治疗机遇
Cancers (Basel). 2023 Feb 6;15(4):1022. doi: 10.3390/cancers15041022.
3
Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer.
推进结直肠癌的靶向治疗:利用配体导向酶前药疗法进行高度特异性干预。
Front Oncol. 2025 May 29;15:1570712. doi: 10.3389/fonc.2025.1570712. eCollection 2025.
4
Exploring the Role of Cellular Interactions in the Colorectal Cancer Microenvironment.探索细胞间相互作用在结直肠癌微环境中的作用。
J Immunol Res. 2025 Apr 11;2025:4109934. doi: 10.1155/jimr/4109934. eCollection 2025.
5
Immunotherapy for colorectal cancer.结直肠癌的免疫治疗。
Front Immunol. 2024 Aug 21;15:1433315. doi: 10.3389/fimmu.2024.1433315. eCollection 2024.
6
Evaluation of peripheral blood inflammation indexes as prognostic markers for colorectal cancer metastasis.评估外周血炎症指标作为结直肠癌转移的预后标志物。
Sci Rep. 2024 Sep 3;14(1):20489. doi: 10.1038/s41598-024-68150-y.
7
Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy.重新定义结直肠癌之战:新兴免疫疗法及其临床疗效的全面综述。
Front Immunol. 2024 Mar 12;15:1350208. doi: 10.3389/fimmu.2024.1350208. eCollection 2024.
微卫星稳定型结直肠癌免疫检查点抑制剂联合策略的进展
Front Oncol. 2023 Feb 2;13:1112276. doi: 10.3389/fonc.2023.1112276. eCollection 2023.
4
TCR-engineered T cell therapy in solid tumors: State of the art and perspectives.T 细胞受体工程化 T 细胞疗法治疗实体瘤:现状与展望。
Sci Adv. 2023 Feb 15;9(7):eadf3700. doi: 10.1126/sciadv.adf3700.
5
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T.实体瘤过继细胞免疫治疗:除 CAR-T 以外的方法
Mol Cancer. 2023 Feb 7;22(1):28. doi: 10.1186/s12943-023-01735-9.
6
The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes.肠道微生物群与肿瘤免疫的串扰:对癌症进展和治疗结果的影响。
Front Immunol. 2023 Jan 16;13:1096551. doi: 10.3389/fimmu.2022.1096551. eCollection 2022.
7
Immunotherapy: Recent Advances and Its Future as a Neoadjuvant, Adjuvant, and Primary Treatment in Colorectal Cancer.免疫疗法:在结直肠癌中的新辅助、辅助和一线治疗中的最新进展及其未来。
Cells. 2023 Jan 8;12(2):258. doi: 10.3390/cells12020258.
8
Do proton pump inhibitors affect the effectiveness of chemotherapy in colorectal cancer patients? A systematic review with meta-analysis.质子泵抑制剂会影响结直肠癌患者化疗的疗效吗?一项荟萃分析的系统评价。
Front Pharmacol. 2022 Dec 12;13:1048980. doi: 10.3389/fphar.2022.1048980. eCollection 2022.
9
Dendritic Cell-Based Immunotherapies and their Potential use in Colorectal Cancer Immunotherapy.基于树突状细胞的免疫疗法及其在结直肠癌免疫治疗中的潜在应用。
J Microsc Ultrastruct. 2021 Jul 9;10(3):107-113. doi: 10.4103/jmau.jmau_20_21. eCollection 2022 Jul-Sep.
10
Regulation of thymidylate synthase: an approach to overcome 5-FU resistance in colorectal cancer.胸苷酸合成酶的调节:克服结直肠癌 5-FU 耐药的一种方法。
Med Oncol. 2022 Oct 29;40(1):3. doi: 10.1007/s12032-022-01864-z.